Autolus Therapeutics Wins FDA Approval for AUCATZYL®
Autolus Therapeutics ( (AUTL) ) has provided an announcement. Autolus Therapeutics has achieved a pivotal milestone with the FDA’s ...
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
MassDevice9h
FDA clears AI-powered breast cancer detection tech from iCad
Cad (Nasdaq:ICAD) announced today that the FDA cleared its ProFound Detection version 4.0 for digital breast tomosynthesis ...
Business Insider17h
Autolus Therapeutics Gains FDA Approval for AUCATZYL®
Autolus Therapeutics ( (AUTL)) has provided an update. Autolus Therapeutics plc has achieved FDA approval for AUCATZYL®, a treatment for relapsed and refractory B-cell acute lymphoblastic leukemia, ...
Medpage Today on MSN21h
FDA Rejects Full Approval of Liver Disease Drug
The FDA in 2016 granted accelerated approval to the FXR agonist as a second-line treatment for adults with PBC, either in ...